MarketInOut Stock Screener Log In | Sign Up

Smith & Nephew Plc

LSE • Healthcare • Medical Devices • Quote as of 10/27/2026 16:37
Smith & Nephew Plc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeLSE
Market Capitalization9,650.99 mln
Float837 mln
Earnings Date02/23/2027

EPS

55.00
Exceptional

P / E

20.41
Premium valuation

1-Year Forecast

1,251.64
Modest upside

Relative Strength

94 / 100
Top performer

Debt / Equity

0.73
Moderate leverage

Pre-Tax Margin

13%
Moderate margin

Business Description

Founded in 1856 and based in Watford, UK, Smith & Nephew is a global medical device company serving healthcare providers across three main areas: orthopaedic reconstruction, sports medicine and ear, nose and throat care, and advanced wound management. Its orthopaedic products cover knee and hip replacements, fracture stabilisation, and deformity correction, while its sports medicine range supports minimally invasive joint surgery and soft tissue repair. The wound care division addresses a broad spectrum of injuries and chronic conditions through dressings, biological treatments, and devices such as negative pressure wound therapy systems.

Key Fundamentals

EPS55.00
P/E20.41
ROE11.85
RPS5.61
ROIC8.85
ROA5.16
Interest Cover6.66
EBITDA, mln1,239
EV / EBITDA9.63
Revenue, mln4,765

Quote Details

Last 1,122.50
Change -14 (-1.23%)
Open 1,133.00
Volume 2,130,485
Turnover 2,391,469,312
Average Volume 2,256,708

Financial Ratios

Pre-Tax Profit Margin13
Leverage Ratio2.13
Current Ratio2.14
Price / Book2.52
Price / Cash Flow9.88
Price / Free Cash Flow15.25
Debt / Equity0.73
Price / Sales2.03
PEG Ratio1.20

Financial Strength

1-Year Target Price1,251.64

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.22% 90 / 100   
1 Month 12.17% 96 / 100   
2 Months 1.5% 63 / 100   
6 Months 0.29% 40 / 100   
1 Year -16.33% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog